Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study
- PMID: 2239898
- DOI: 10.1093/oxfordjournals.aje.a115726
Racial/ethnic differences in HIV-1 seroprevalence and risky behaviors among intravenous drug users in a multisite study
Abstract
Differences in human immunodeficiency virus type 1 (HIV-1) seroprevalence and patterns of drug-use and sexual behaviors were examined among Hispanic, black, and white intravenous drug users recruited at multiple sites in Worcester, Massachusetts. A total of 1,092 (786 males, 306 females) intravenous drug users were interviewed, and HIV-1 antibody test results were available for 874 (80.0%). After adjustment for demographic differences, black males were significantly less likely to report risky drug-use behaviors (ever sharing needles and recently visiting shooting galleries) compared with white males. In contrast, Hispanic males were significantly more likely to report recent risky drug-use behaviors (sharing needles in New York City, daily needle-sharing, and visiting shooting galleries). Both groups were less likely to report risky sexual behaviors compared with whites. The odds ratios for HIV-1 seropositivity remained significantly greater than 1 for Hispanics compared with whites (odds ratio = 4.5) and maintained marginal significance for blacks compared with whites (odds ratio = 2.1) when adjusted for risky behaviors and demographic variables. The different patterns of drug-use and sexual behaviors by race/ethnicity indicate the need for interventions targeted to specific populations.
Similar articles
-
What is the significance of black-white differences in risky sexual behavior?J Natl Med Assoc. 1994 Oct;86(10):745-59. J Natl Med Assoc. 1994. PMID: 7807559 Free PMC article.
-
Similarities and differences by race/ethnicity in changes of HIV seroprevalence and related behaviors among drug injectors in New York City, 1991-1996.J Acquir Immune Defic Syndr. 1999 Sep 1;22(1):83-91. doi: 10.1097/00042560-199909010-00011. J Acquir Immune Defic Syndr. 1999. PMID: 10534151
-
Cocaine use and HIV infection in intravenous drug users in San Francisco.JAMA. 1989 Jan 27;261(4):561-5. JAMA. 1989. PMID: 2909798
-
HIV infection among intravenous drug users: epidemiology and risk reduction.AIDS. 1987 Jul;1(2):67-76. AIDS. 1987. PMID: 3130084 Review.
-
Prevalence of HIV infection among intravenous drug users in the United States.JAMA. 1989 May 12;261(18):2677-84. JAMA. 1989. PMID: 2651732 Review.
Cited by
-
HIV infection among people who inject drugs: the challenge of racial/ethnic disparities.Am Psychol. 2013 May-Jun;68(4):274-85. doi: 10.1037/a0032745. Am Psychol. 2013. PMID: 23688094 Free PMC article.
-
HIV transmission and the cost-effectiveness of methadone maintenance.Am J Public Health. 2000 Jul;90(7):1100-11. doi: 10.2105/ajph.90.7.1100. Am J Public Health. 2000. PMID: 10897189 Free PMC article.
-
Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs.Am J Public Health. 2009 Oct;99 Suppl 2(Suppl 2):S445-51. doi: 10.2105/AJPH.2008.159327. Am J Public Health. 2009. PMID: 19797757 Free PMC article.
-
Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.Am J Public Health. 1995 Nov;85(11):1538-42. doi: 10.2105/ajph.85.11.1538. Am J Public Health. 1995. PMID: 7485667 Free PMC article.
-
The consistency of self-reported HIV risk behavior among injection drug users.Am J Public Health. 1994 Dec;84(12):1965-70. doi: 10.2105/ajph.84.12.1965. Am J Public Health. 1994. PMID: 7998638 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources